Free Trial

JPMorgan Chase & Co. Has $474,000 Stock Holdings in agilon health, inc. (NYSE:AGL)

agilon health logo with Medical background

JPMorgan Chase & Co. decreased its stake in shares of agilon health, inc. (NYSE:AGL - Free Report) by 82.4% during the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 249,346 shares of the company's stock after selling 1,166,073 shares during the period. JPMorgan Chase & Co. owned approximately 0.06% of agilon health worth $474,000 as of its most recent SEC filing.

Several other large investors also recently made changes to their positions in AGL. EntryPoint Capital LLC grew its position in agilon health by 275.8% in the 4th quarter. EntryPoint Capital LLC now owns 233,069 shares of the company's stock worth $443,000 after purchasing an additional 171,052 shares during the last quarter. Vanguard Group Inc. grew its stake in shares of agilon health by 0.9% in the fourth quarter. Vanguard Group Inc. now owns 31,112,407 shares of the company's stock valued at $59,114,000 after buying an additional 272,787 shares in the last quarter. Samalin Investment Counsel LLC boosted its holdings in shares of agilon health by 378.2% during the fourth quarter. Samalin Investment Counsel LLC now owns 60,545 shares of the company's stock worth $115,000 after acquiring an additional 47,885 shares during the period. KLP Kapitalforvaltning AS bought a new position in agilon health during the 4th quarter worth $111,000. Finally, Intech Investment Management LLC raised its holdings in shares of agilon health by 99.6% during the 4th quarter. Intech Investment Management LLC now owns 115,693 shares of the company's stock worth $220,000 after buying an additional 57,726 shares in the last quarter.

Analyst Ratings Changes

A number of brokerages recently issued reports on AGL. TD Cowen increased their target price on agilon health from $3.50 to $6.00 and gave the stock a "hold" rating in a report on Tuesday, April 15th. Royal Bank of Canada upped their target price on agilon health from $3.00 to $3.50 and gave the stock an "outperform" rating in a research note on Wednesday, February 26th. Sanford C. Bernstein raised agilon health from a "market perform" rating to an "outperform" rating and raised their target price for the stock from $3.30 to $8.50 in a research note on Tuesday, April 8th. Cowen reaffirmed a "hold" rating on shares of agilon health in a research note on Tuesday, April 15th. Finally, JMP Securities restated a "market perform" rating on shares of agilon health in a research note on Monday, April 28th. Two equities research analysts have rated the stock with a sell rating, twelve have assigned a hold rating and four have assigned a buy rating to the stock. Based on data from MarketBeat, agilon health currently has an average rating of "Hold" and an average target price of $4.81.

Get Our Latest Analysis on AGL

agilon health Stock Performance

Shares of agilon health stock traded down $1.07 during trading hours on Wednesday, reaching $3.40. The company's stock had a trading volume of 10,036,470 shares, compared to its average volume of 4,890,430. agilon health, inc. has a one year low of $1.50 and a one year high of $7.73. The stock has a market cap of $1.40 billion, a P/E ratio of -3.61 and a beta of 0.38. The company has a debt-to-equity ratio of 0.06, a quick ratio of 1.29 and a current ratio of 1.29. The company's 50 day simple moving average is $4.27 and its 200 day simple moving average is $3.18.

agilon health (NYSE:AGL - Get Free Report) last announced its earnings results on Tuesday, May 6th. The company reported $0.03 earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.01) by $0.04. agilon health had a negative net margin of 6.88% and a negative return on equity of 47.84%. The company had revenue of $1.53 billion for the quarter, compared to the consensus estimate of $1.50 billion. During the same period in the previous year, the business earned ($0.02) EPS. The company's revenue was down 4.5% on a year-over-year basis. As a group, analysts expect that agilon health, inc. will post -0.59 EPS for the current fiscal year.

About agilon health

(Free Report)

agilon health, inc. provides healthcare services for seniors through primary care physicians in the communities of the United States. It offers a platform that manages the total healthcare needs of the patients by subscription-like per-member per-month. The company was formerly known as Agilon Health Topco, Inc and changed its name to agilon health, inc.

Read More

Institutional Ownership by Quarter for agilon health (NYSE:AGL)

Should You Invest $1,000 in agilon health Right Now?

Before you consider agilon health, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and agilon health wasn't on the list.

While agilon health currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Investing Strategies To Help Grow Your Retirement Income Cover

Need to stretch out your 401K or Roth IRA plan? Use these time-tested investing strategies to grow the monthly retirement income that your stock portfolio generates.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

NVIDIA Earnings Preview: HUGE Stock Move Ahead
These 5 Small Stocks Could Deliver Huge Returns
ACT FAST! Congress Is POURING Into This Stock

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines